Welcome to NDF Research
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog
​US Life Science Patents to New Zealand assignees, 2014

​US Life Science Patents to New Zealand assignees, 2014

By Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 9096
The US Patent Office issues new patents every Tuesday. New Zealand assignees generally get one or two healthcare and biotech-related patents a month. Here are the 15 US patents relevant to New Zealand's Life Sciences sector that issued in 2014.
US Patent 8,889,636
Title: Anti-microbial compositions
​Issued: 18 November 2014
Assignee: Biotelliga
Description: This patent antifungal compounds extracted from Epicoccum nigrum.
US Patent 8,877,465
Title: Production of ultrapure EPA and polar lipids from largely heterotrophic culture
​Issued: 4 November 2014
Assignee: Photonz
Description: This patent covers a method for producing EPA from micro-organisms such as the diatom Nitzschia laevis.
US Patent 8,835,397
Title: Macrocyclic lactone tablet formulation
​Issued: 16 September 2014
Assignee: Bayer New Zealand
Description: This patent covers an improved formulation of ivermectin.
US Patent 8,821,921
Title: Vitamin D3 for the transdermal treatment of pain and inflammation
 Issued: 2 September 2014
Assignee: Anzamed International (Dr John Lyftogt)
Description: This patent covers the use of vitamin D3 in treating neuropathic pain.
US Patent 8,809,301
Title: Surgical hydrogel
Issued: 19 August 2014​
Assignee: Robinson Squidgel Ltd (33%), University of Otago (33%),  Adelaide Research & Innovation (Australia 33%).
Description: The patent covers a gel useful in reducing post-surgery sinus scarring, where the actives come from polymers found in squid and crab shell.
US Patent 8,791,117
Title: Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
​Issued: 29 July 2014
Assignee: Neuren Pharmaceuticals (ASX: NEU)
Description: This patent covers Neuren's modified tripeptide for the treatment of cognitive impairment.
US Patent 8,784,795
Title: Methods for determining personalized treatment compositions for prostate cancer and breast cancer
​Issued: 22 July 2014
Assignee: Caldera Health
Description: This patent covers the combination of an immune cell activating agent and an antigen display enhancing agent in order to determine the optimal therapy for each patient.
US Patent 8,758,781
Title: Tissue scaffolds derived from forestomach extracellular matrix
​Issued: 24 June 2014
Assignee: Aroa Biosurgery
Description: This patent covers extracellular matrix scaffolds derived from the forestomach of a ruminant, useful in tissue repair.  
US Patent 8,709,448
Title: Anti-infective agents and uses thereof
​Issued: 29 April 2014
Assignee: Innate Immunotherapeutics (ASX: IIL)
Description: This patent covers the anti-infective applications of a muramyl dipeptide microparticle, which has immunostimulatory properties.
US Patent 8,703,699
Title: Lactoferrin
​Issued: 22 April 2014
Assignee: Auckland UniServices (University of Auckland)
Description: This patent covers a formulation of lactoferrin useful in treating bone-related disorders.
US Patent 8,679,527
Title: Antimicrobial compositions
​Issued: 25 March 2014
Assignee: Manuka Health
Description: This patent covers the antimicrobial actives in honey from Leptospermum scoparium.
US Patent 8,669,084
Title: Functional lipid constructs
​Issued: 11 March 2014
Assignee: Kode Biotech
Description: This patent covers peptide-lipid constructs that spontaneously incorporate into the membranes of cells.
US Patent 8,637,567
Title: Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid
​Issued: 28 January 2014
Assignee: Neuren Pharmaceuticals (ASX: NEU)
Description: This patent covers an analogue to the tripeptide glycyl-L-prolyl-L-glutamic acid useful for treating cognitive impairment.
US Patent 8,637,473
Title: Synthetic membrane anchors
​Issued: 28 January 2014
Assignee:  Kode Biotech
Description:  This patent covers water soluble synthetic glycolipids incorporatable into a cell membrane.
US Patent 8,633,248
Title: Parenteral selenomethionine for production of selenium-rich foods
​Issued: 21 January 2014
Assignee: AgResearch Ltd
Description: This patent covers a selenomethionine formulation as a selenium dietary supplement.

Copyright © 2016 NDF Research
Proudly powered by Weebly
  • Introducing NDF
  • About us
    • About our Senior Analyst
    • Disclaimer relating to research and web content
    • Financial Services Guide and General Advice Warning
  • What we do
    • The Rise of the New Analysts
    • MiFID II
  • Our sector
    • ASX-Listed Life Science companies we watch >
      • ASX-listed Life Science companies, >$200m
      • ASX-listed Life Science companies, $100-200m
    • About Australia and Australians
    • Australia and the Life Sciences
    • Life Sciences in New Zealand >
      • Building the New Zealand Life Sciences sector
    • A tour of Life Sciences Down Under
    • Australia's global competitiveness in Life Sciences >
      • Australia's Life Sciences Innovation Rating
      • Australia's Life Sciences clusters
      • Australia's World-Class Universities
      • Australia's Nobel Laureates
      • Australia's public policy support for Life Sciences
      • Australia's support for women in Life Sciences
    • The Coming Boom in Australian Life Sciences >
      • Welcome to Australia's Life Sciences Boom
    • Key organisations in the Life Science sector in Australia and New Zealand
    • Notable people in the Life Sciences sector in Australia and New Zealand >
      • Great CEOs
      • 2017 Red Hat Award Winners
      • 2018 Red Hat Award Winners
      • 2019 Red Hat Award Winners
    • The NDF Life Sciences Index >
      • 2016-2017 Year in Review
  • Our clients
  • Contact us
    • linkedin
    • Twitter
    • NDF Research Youtube Channel
  • Latest research
    • Comprehensive update reports
    • Shorter update reports
    • Initiation reports >
      • Admedus
      • Invion
    • Media and interviews
    • Presentations
    • Previous research and media, 2003-2015
    • A Brief History of the Life Sciences in Australia
    • In our library
    • Intellectual property >
      • Australian PCT patent applications
      • New Zealand PCT patent applications
      • PCT patent applications, last twelve months >
        • 2017 PCT patent applications
        • 2016 PCT patent applications
        • 2015 PCT patent applications
        • 2014 PCT patent applications
        • 2013 PCT patent applications
      • US patents >
        • 2017 US patents
        • 2016 US patents
        • 2015 US patents
        • 2014 US patents
    • Publications
    • Glossary
    • Global Life Science companies to watch
  • Blog